Anna Beutler

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial

Christian Antoni, Gerald G. Krueger, Kurt de Vlam et al. · Annals of the Rheumatic Diseases · 2005 · 716 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study

Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease et al. · Arthritis & Rheumatism · 2009 · 603 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial

Robert D. Inman, John C. Davis, Désirée van der Heijde et al. · Arthritis & Rheumatism · 2008 · 593 citations

Medicine, Clinical Sciences, Pharmacotherapy +7

A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis

Nicolino Ruperto, Daniel J. Lovell, Rubén Cuttica et al. · Arthritis & Rheumatism · 2007 · 411 citations

Medicine, Pediatrics, Pharmacotherapy +12

Golimumab in psoriatic arthritis: One‐year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo‐controlled trial

Arthur Kavanaugh, Désirée van der Heijde, Iain B. McInnes et al. · Arthritis & Rheumatism · 2012 · 209 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14